Engaging outside experts in patent review could curtail the granting of unmerited patents, which can lead to high prices for essential drugs in resource-poor countries.
Engaging outside experts in patent review could curtail the granting of unmerited patents, which can lead to high prices for essential drugs in resource-poor countries.
Learn more about how you can help build a more equitable system for all